3,343
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Bezlotoxumab prevents extraintestinal organ damage induced by Clostridioides difficile infection

, , , , , , , , & show all
Article: 2117504 | Received 26 Apr 2022, Accepted 22 Aug 2022, Published online: 31 Aug 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jessica E. Buddle & Robert P. Fagan. (2023) Pathogenicity and virulence of Clostridioides difficile. Virulence 14:1.
Read now

Articles from other publishers (3)

Shannon L. Kordus, Heather K. Kroh, Rubén Cano Rodríguez, Rebecca A. Shrem, F. Christopher Peritore-Galve, John A. Shupe, Brian E. Wadzinski, D. Borden Lacy & Benjamin W. Spiller. (2023) Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo. PLOS Pathogens 19:10, pages e1011496.
Crossref
Sarah E. Lucas, Sarah L. Walton, Katrina M. Mirabito ColafellaSteven J. Mileto, Dena Lyras & Kate M. Denton. (2023) Antihypertensives and Antibiotics: Impact on Intestinal Dysfunction and Hypertension. Hypertension 80:7, pages 1393-1402.
Crossref
Kusum Kharga, Lokender Kumar & Sanjay Kumar Singh Patel. (2023) Recent Advances in Monoclonal Antibody-Based Approaches in the Management of Bacterial Sepsis. Biomedicines 11:3, pages 765.
Crossref